Double - blind randomized evaluation of <font color="blue">intercostal_1</font> <font color="blue">nerve_1</font> <font color="blue">blocks_1</font> as an adjuvant to <font color="blue">subarachnoid_1</font> <font color="blue">administered_1</font> <font color="blue">morphine_2</font> for post - thoracotomy analgesia . 
<br>
<br> BACKGROUND AND OBJECTIVES Thoracotomy is associated with pain and compromised pulmonary function . <font color="blue">Intercostal_1</font> <font color="blue">nerve_1</font> <font color="blue">blocks_1</font> <font color="blue">(_1</font> <font color="blue">INB_1</font> <font color="blue">)_1</font> and <font color="blue">subarachnoid_1</font> <font color="blue">morphine_2</font> <font color="blue">(_1</font> <font color="blue">SM_1</font> <font color="blue">)_1</font> act on different portions of the pain pathway . Each is effective for post - thoracotomy pain relief . The combination of these two modalities in relieving post - thoracotomy pain and improving postoperative pulmonary function has not been investigated . 
<br> METHODS In a double - blind study , 20 patients undergoing <font color="blue">lateral_1</font> <font color="blue">thoracotomy_2</font> <font color="blue">for_1</font> <font color="blue">lung_1</font> <font color="blue">resection_1</font> <font color="blue">were_1</font> <font color="blue">randomized_1</font> <font color="blue">to_1</font> <font color="blue">receive_1</font> <font color="blue">0.5_2</font> <font color="blue">mg_2</font> <font color="blue">SM_4</font> <font color="blue">preoperatively_3</font> <font color="blue">and_3</font> <font color="blue">INB_4</font> <font color="blue">with_4</font> <font color="blue">bupivacaine_5</font> <font color="blue">(_4</font> <font color="blue">INB+_4</font> <font color="blue">)_4</font> <font color="blue">prior_2</font> <font color="blue">to_2</font> <font color="blue">wound_2</font> <font color="blue">closure_2</font> <font color="blue">or_2</font> <font color="blue">0.5_2</font> <font color="blue">mg_2</font> <font color="blue">SM_4</font> <font color="blue">with_4</font> <font color="blue">INB_4</font> <font color="blue">using_4</font> <font color="blue">saline_5</font> <font color="blue">(_3</font> <font color="blue">INB-_3</font> <font color="blue">)_2</font> <font color="blue">._2</font> Visual analog scale pain scores at rest , with cough , and with movement of the ipsilateral arm , forced expiratory volume in 1 second ( FEV1 ) , and forced vital capacity ( FVC ) were measured at 4 , 24 , 48 , and 72 hours after the operation . Opioid use was measured during the initial 24 hours after the operation . 
<br> RESULTS At 4 hours , the <font color="blue">INB+_1</font> group demonstrated better FEV1 ( 56.6% vs. 40.4% of baseline , P < .05 ) and FVC values ( 54.6% vs. 39.6% of baseline , P < .05 ) and less resting and cough pain ( P < .05 ) . However , FEV1 continued to decline in the <font color="blue">INB+_1</font> group at 24 hours to lower than the <font color="blue">INB-_1</font> group although pain scores were similar beyond 4 hours . Opioid usage during the first 24 hours was similar ( <font color="blue">INB-_1</font> <font color="blue">,_1</font> 16.7 mg vs. <font color="blue">INB+_1</font> <font color="blue">,_1</font> 13.2 mg , P = .7 ) . 
<br> CONCLUSIONS Although postoperative <font color="blue">INB_1</font> provided modest improvements in pain and pulmonary function when used as an adjuvant to 0.5 mg <font color="blue">SM_1</font> for post - thoracotomy analgesia , the benefits were transient . The authors do not recommend adding <font color="blue">INB_1</font> for patients undergoing <font color="blue">lateral_1</font> <font color="blue">thoracotomy_1</font> who receive 0.5 mg <font color="blue">SM_1</font> <font color="blue">._1</font>